Showing results (121-130 of 126) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2021
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trialA Llop-Guevara, S Loibl, G Villacampa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2020
Olaparib monotherapy as primary treatment in unselected triple negative breast cancerH P Eikesdal, S Yndestad, A Elzawahry, et al.ESMO Open|September 26, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trialE D Capoluongo, B Pellegrino, L Arenare, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2024
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancerE Harvey-Jones, M Raghunandan, L Robbez-Masson, et al.BJOG : an International Journal of Obstetrics and Gynaecology|August 23, 2014
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysisE Schuit, S Stock, L Rode, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerC Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, et al.Pageof 13